• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Euro Surveill. Laboratory preparedness in EU/EEA countries for detection of novel avian influenza A(H7N9) virus, May 2013

Giuseppe

Emeritus
[Source: Eurosurveillance, full page: (LINK). Abstract, edited.]


Eurosurveillance, Volume 19, Issue 4, 30 January 2014

Surveillance and outbreak reports

Laboratory preparedness in EU/EEA countries for detection of novel avian influenza A(H7N9) virus, May 2013

E Broberg <SUP>1</SUP>, D Pereyaslov<SUP>2</SUP>, M Struelens<SUP>3</SUP>, D Palm<SUP>3</SUP>, A Meijer<SUP>4</SUP>, J Ellis<SUP>5</SUP>, M Zambon<SUP>5</SUP>, J McCauley<SUP>6</SUP>, R Daniels<SUP>6</SUP>
<SUP></SUP>
<SUP>1</SUP>Surveillance and Response Support, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden ? 2 World Health Organization Regional Office for Europe (WHO/Euro), Copenhagen, Denmark - 3 Microbiology Coordination section, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden - 4 Division of Virology, Centre for Infectious Disease Research, Diagnostics and Screening, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands - 5 Public Health England (PHE) Microbiology Services - Colindale, London, United Kingdom - 6 World Health Organization (WHO) Collaborating Centre for Reference and Research on Influenza, Medical Research Council (MRC) National Institute for Medical Research (NIMR), Mill Hill, London , United Kingdom
_____

Citation style for this article: Broberg E, Pereyaslov D, Struelens M, Palm D, Meijer A, Ellis J, Zambon M, McCauley J, Daniels R. Laboratory preparedness in EU/EEA countries for detection of novel avian influenza A(H7N9) virus, May 2013. Euro Surveill. 2014;19(4):pii=20682. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20682
Date of submission: 29 August 2013

______

Following human infections with novel avian influenza A(H7N9) viruses in China, the European Centre for Disease Prevention and Control, the World Health Organization (WHO) Regional Office for Europe and the European Reference Laboratory Network for Human Influenza (ERLI-Net) rapidly posted relevant information, including real-time RT-PCR protocols. An influenza RNA sequence-based computational assessment of detection capabilities for this virus was conducted in 32 national influenza reference laboratories in 29 countries, mostly WHO National Influenza Centres participating in the WHO Global Influenza Surveillance and Response System (GISRS). Twenty-seven countries considered their generic influenza A virus detection assay to be appropriate for the novel A(H7N9) viruses. Twenty-two countries reported having containment facilities suitable for its isolation and propagation. Laboratories in 27 countries had applied specific H7 real-time RT-PCR assays and 20 countries had N9 assays in place. Positive control virus RNA was provided by the WHO Collaborating Centre in London to 34 laboratories in 22 countries to allow evaluation of their assays. Performance of the generic influenza A virus detection and H7 and N9 subtyping assays was good in 24 laboratories in 19 countries. The survey showed that ERLI-Net laboratories had rapidly developed and verified good capability to detect the novel A(H7N9) influenza viruses.


-
--------
 
Back
Top Bottom